28 & 29 NOVEMBER 2025
Learn cutting-edge full-face techniques with Dr. Tapan Patel & Dr. Dimitris Sykianakis.
This intensive two-day program is designed to help aesthetic practitioners master their skills and confidence in full-face injectables. The course combines anatomy, live injection demonstrations, and hands-on toxin training to help practitioners enhance safety, precision, and confidence in full-face aesthetics.
Guided by world-renowned faculty, it integrates evidence-based anatomy with advanced techniques in toxin, fillers, biostimulators, and skin quality, providing a comprehensive, practice-oriented learning experience.
This program is open in Greece exclusively to certified Dermatologists and Plastic Surgeons. Internationally, it welcomes licensed Healthcare Professionals from all specialties practicing aesthetics.
Dr. Tapan Patel is an internationally recognized aesthetic physician with over 27 years of clinical experience, including more than two decades dedicated to aesthetic medicine. As the Founder and Medical Director of PHI Clinic in London, he is renowned for his advanced injection techniques, precision, and holistic approach to facial rejuvenation. In 2024, he was honored with the Outstanding Achievement in Aesthetic Medicine award by the UK industry. A passionate educator, Dr. Patel lectures extensively at global conferences and continues to promote excellence, ethics, and innovation in aesthetic practice.
DIMITRIOS SYKIANAKIS, AESTHETIC EXPERT, GREECE
Dr. Dimitris Sykianakis is an internationally recognized Anti-Aging and Aesthetic Medicine doctor
and trainer with over 25 years of experience. He has performed more than 70,000 injectable
treatments and is widely respected for his role as an international KOL with the Allergan Medical
Institute, where he has trained hundreds of practitioners across more than 15 countries. A
frequent speaker at international congresses and symposia, he is known for advancing
innovative injection techniques and encouraging peer-to-peer knowledge exchange. Since 2018,
Dr. Sykianakis has been part of the selective MdM program and holds a PhD in
OnabotulinumtoxinA.